Genzyme Biosurgery, Excigen to Collaborate in Developing Gene Therapy for Cardiac Arrhythmias
01-Apr-2003 -
Genzyme Biosurgery, a division of Genzyme Corp., announced today that it has entered into a
collaboration with Excigen, Inc., a recently created biotechnology company in Baltimore, Maryland focused on developing gene therapies for treating cardiac arrhythmias. Genzyme Biosurgery, which has an ...
atrial fibrillation
biotechnology
cardiac arrhythmias
+7